Prime Minister Narendra Modi said Covid-19 vaccination was being done for free at government hospitals. PM Modi was addressing Janaushadhi Diwas celebrations via video conferencing. “We are proud of our scientists for we now have ‘Made in India’ vaccine for us and the rest of the world. Covid-19 vaccination is being done for free at government hospitals in India. Covid-19 vaccine costs Rs 250 in private hospitals which is the cheapest in world. Even I got my first dose of Covid-19.” PM Modi added, “1.5 lakh health and wellness centre are being made in villages out of which 50,000 have already started functioning. These centres will be equipped to tackle serious health issues.” Watch the full video for more.
Credit: HT Digital Content Duration: 02:15Published
Prime Minister Narendra Modi inaugurated 7500th Janaushadhi Kendra at North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences (NEIGRIHMS) in Shillong. The event took place via video conferencing on March 07. While addressing the event, PM Modi said, "Today, we have 'Made in India' vaccines for our country and for the world. COVID-19 vaccination is being done for free at government hospitals and at the cost of Rs 250 at private hospitals. I have also taken the first dose of the COVID-19 vaccine."
As per the data released by Ministry of Health and Family Welfare (MoHFW), India on March 07 reported single-day spike of 18,711 new coronavirus cases in the last 24 hours. 100 deaths in the same period pushed the COVID-19 toll in the country to 1,57,756. India's confirmed cases of coronavirus stand at 1,12,10,799 which include 1,84,523 active infections. More than 1,08,68,520 people have recovered from the virus with 14,392 new discharges in last 24 hours. Till date the total vaccination is 2,09,22,344. According to Indian Council of Medical Research (ICMR), a total of 7,37,830 samples were tested on March 06. Cumulative samples tested for COVID-19 till March 06 are 22,14,30,507.
Johnson & Johnson said on Thursday it has asked U.S. health regulators to authorize its single-dose COVID-19 vaccine for emergency use, and it will apply to European authorities in coming weeks. Gloria Tso reports.
A fourth coronavirus vaccine could be approved for use in the UK within weeks as late-stage trials suggested it was 89% effective in preventing Covid-19.
The UK has secured 60 million doses of the Novavax jab, which is believed to offer protection against the new UK and South African variants.
Two vaccines have already been rolled out in the UK – from Pfizer and Oxford/AstraZeneca – while a third from Moderna has been approved for use.
The Novavax jab will be delivered in the second half of 2021 if it receives MHRA approval. Report by Avagninag. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn
The Biden administration will purchase 200 million more coronavirus vaccines and funnel more to states now, in a bid to deliver on the president's promise to curb the pandemic. This report produced by Jillian Kitchener.
Sweden envoy Klas Molin spoke on the Free Trade Agreement (FTA) between European Union and India. Molin said FTA will be negotiated at an aggregate level as per the mechanism set up during the last summit. “I know there are high talks going on about investment and trade. There is a special mechanism set up during the last summit between India and the EU. So, agreements on this will be negotiated at an aggregate level. Bilaterally a lot is happening as Swedish companies are employing heavily. Swedish companies are employing lots of people, creating jobs and growth,” he said. Earlier on Friday, PM Modi held a virtual interaction with his Swedish counterpart Stefan Lofven. The two leaders discussed bilateral ties and called for further cooperation on climate change.
Credit: HT Digital Content Duration: 01:53Published
Sweden Ambassador to India, Klas Molin, on March 06 said that the Free Trade Agreement (FTA) between the European Union (EU) and India will be negotiated at an aggregate level as per the special mechanism set up during the last summit. "Trade agreements, as Sweden is member of EU, is negotiated by European Commission. Talks on for investment and trade, special mechanism was set up during last summit between India and EU so agreements on it will be negotiated at aggregate level," said Molin. On Mar 05, Prime Minister Narendra Modi held a virtual interaction with his Swedish counterpart Stefan Lofven where the two leaders discussed bilateral ties and called for further cooperation on climate change.
Sir Keir Starmer has played down reports of a confrontation with Boris Johnson following Wednesday's Prime Minister's Questions. The Labour leader was forced to apologise for denying having previously supported the UK remaining a member of the European Medicines Agency (EMA) after Brexit. Mr Johnson and Sir Keir were seen walking out of the Commons together following their PMQs clash and continued their conversation while standing just outside the chamber. According to eyewitnesses quoted by the Sun, the political rivals were seen having a "heated discussion" about the Prime Minister's EMA remarks, allegedly resulting in Sir Keir being "led away" by ally and Labour whip Chris Matheson. Sir Keir was asked about the incident on Thursday whilst visiting a vaccine centre in Hertfordshire. "We were discussing as we went out", the Labour lead said; "that's not unusual'
Report by Thomasl. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn
Boris Johnson has claimed Britain’s Covid-19 vaccine programme would still be at the “starting blocks” under Sir Keir Starmer, as the pair clashed in the House of Commons.The Prime Minister said the Labour leader had repeatedly called for the UK to stay in the European Medicines Agency, and suggested such a move would have hampered the UK’s response to the pandemic.
Credit: PA - Press Association STUDIO Duration: 01:29Published
The vice chair of EMA’s human medicines committee, Bruno Sepodes, says theOxford/AstraZeneca has been authorised for use across the EU. It came amid adeepening row between the EU and AstraZeneca over vaccine supply shortages inthe bloc – with Brussels announcing an export ban on some jabs.
Credit: PA - Press Association STUDIO Duration: 01:01Published